Avanir Pharmaceuticals (Nasdaq: AVNR) 110.7% HIGHER; received FDA approval for NUEDEXTA as the first treatment for pseudobulbar affect. Pseudobulbar affect, or PBA, occurs secondary to a number of unrelated neurological condition, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying.

Wilmington Trust (NYSE: WL) 42.2% LOWER; to merge with M&T Bank (NYSE: MTB) in a deal valued at $341 million.
Wilmington Trust holders will get 0.51372 shares of M&T per share of WL they own. On a per share basis, the deal is valued at $3.84.

Biodel Inc. (Nasdaq: BIOD) 41.6% LOWER; received a Complete